{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:19:55Z","timestamp":1791400795539,"version":"4.3.3"},"reference-count":60,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Braz J Med Biol Res"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1590\/s0100-879x2005000400001","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T17:00:06Z","timestamp":1114621206000},"page":"477-486","source":"Crossref","is-referenced-by-count":15,"title":["Genotoxic, neurotoxic and neuroprotective activities of apomorphine and its oxidized derivative 8-oxo-apomorphine"],"prefix":"10.1590","volume":"38","author":[{"given":"J.N.","family":"Picada","sequence":"first","affiliation":[{"name":"Universidade Luterana do Brasil, Brasil; Universidade Federal do Rio Grande do Sul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Roesler","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.P.","family":"Henriques","sequence":"additional","affiliation":[{"name":"Universidade Luterana do Brasil, Brasil; Universidade Federal do Rio Grande do Sul"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","first-page":"241","article-title":"Oxidative stress: a role in the pathogenesis of Parkinson's disease","volume":"29","author":"Gotz ME","year":"1990","journal-title":"Journal of Neural Transmission","ISSN":"https:\/\/id.crossref.org\/issn\/0300-9564","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1991.tb06358.x","article-title":"Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease","volume":"57","author":"Ben-Shachar DP","year":"1991","journal-title":"Journal of Neurochemistry","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3042","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/ana.410320616","article-title":"The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it","volume":"32","author":"Fahn S","year":"1992","journal-title":"Annals of Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.1999.tb07977.x","article-title":"The pivotal role of iron in NF-kappaB activation and nigrostriatal dopaminergic neurodegeneration: Prospects for neuroprotection in Parkinson's disease with iron chelators","volume":"890","author":"Youdim MBH","year":"1999","journal-title":"Annals of the New York Academy of Sciences","ISSN":"https:\/\/id.crossref.org\/issn\/0077-8923","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0301-0082(95)00029-1","article-title":"Oxidative stress and antioxidant therapy in Parkinson's disease","volume":"48","author":"Ebadi M","year":"1996","journal-title":"Progress in Neurobiology","ISSN":"https:\/\/id.crossref.org\/issn\/0301-0082","issn-type":"print"},{"key":"ref6","first-page":"24","article-title":"Oxidative mechanisms in nigral cell death in Parkinson's disease","volume":"13","author":"Jenner P","year":"1998","journal-title":"Movement Disorders","ISSN":"https:\/\/id.crossref.org\/issn\/0855-3185","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia","volume":"36","author":"Sian J","year":"1994","journal-title":"Annals of Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"key":"ref8","first-page":"92","article-title":"Increased levels of hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study","volume":"9","author":"Dexter DT","year":"1994","journal-title":"Movement Disorders","ISSN":"https:\/\/id.crossref.org\/issn\/0855-3185","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0014-5793(94)01056-0","article-title":"Intense oxidative DNA damage promoted by L-dopa and its metabolites: Implications for neurodegenerative disease","volume":"353","author":"Spencer JP","year":"1994","journal-title":"FEBS Letters","ISSN":"https:\/\/id.crossref.org\/issn\/0014-5793","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1515\/REVNEURO.1997.8.3-4.223","article-title":"Apoptosis, neurotrophic factors and neurodegeneration","volume":"8","author":"Dragunow M","year":"1997","journal-title":"Reviews in the Neurosciences","ISSN":"https:\/\/id.crossref.org\/issn\/0334-1763","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0378-4347(85)80091-8","article-title":"Determination of apomorphine in rat plasma and brain by high-performance liquid chromatography with electrochemical detection","volume":"338","author":"Bianchi G","year":"1985","journal-title":"Journal of Chromatography","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9673","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1054-3589(08)60482-2","article-title":"Pharmacology and neurochemistry of apomorphine","volume":"15","author":"Di Chiara G","year":"1978","journal-title":"Advances in Pharmacology and Chemotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/0065-3144","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/106002809502900310","article-title":"Apomorphine for motor fluctuations and freezing in Parkinson's disease","volume":"29","author":"Corboy DL","year":"1995","journal-title":"Annals of Pharmacotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/1060-0280","issn-type":"print"},{"key":"ref14","first-page":"28","article-title":"Peripheral and central pharmacokinetics of apomorphine and its effect on dopamine metabolism in humans","volume":"10","author":"Pzedborski S","year":"1995","journal-title":"Movement Disorders","ISSN":"https:\/\/id.crossref.org\/issn\/0855-3185","issn-type":"print"},{"key":"ref15","first-page":"633","article-title":"Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham DG","year":"1978","journal-title":"Molecular Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0026-895X","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0891-5849(92)90182-G","article-title":"Biochemical and toxicological properties of the oxidation products of catecholamines","volume":"13","author":"Bindolli A","year":"1992","journal-title":"Free Radical Biology and Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0891-5849","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-4165(98)00036-1","article-title":"Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects","volume":"1381","author":"Segura-Aguillar J","year":"1998","journal-title":"Biochimica et Biophysica Acta","ISSN":"https:\/\/id.crossref.org\/issn\/0005-2728","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0920-9964(97)00005-4","article-title":"Oxidative reactions and schizophrenia: A review-discussion","volume":"24","author":"Smythies JR","year":"1997","journal-title":"Schizophrenia Research","ISSN":"https:\/\/id.crossref.org\/issn\/0920-9964","issn-type":"print"},{"key":"ref19","first-page":"73","article-title":"Toxic effects of apomorphine on rat cultured neurons and glial C6 cells, and protection with antioxidants","volume":"66","author":"El-Bach\u00e1 RS","year":"2001","journal-title":"Biochemical Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0006-2952","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-0749.1992.tb00008.x","article-title":"Melanin biosynthesis from dopamine: II. A mass spectrometric and collisional spectroscopic investigation","volume":"5","author":"Costa C","year":"1992","journal-title":"Pigment Cell Research","ISSN":"https:\/\/id.crossref.org\/issn\/0893-5785","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2174\/1381612003399581","article-title":"Dopamine agonists in the treatment of Parkinson's disease - past, present and future","volume":"6","author":"Sit SY","year":"2000","journal-title":"Current Pharmaceutical Design","ISSN":"https:\/\/id.crossref.org\/issn\/1381-6128","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0891-5849(93)90055-Y","article-title":"Iron reducing and free radical scavenging properties of apomorphine and some related benzylisoquinolines","volume":"15","author":"Ubeda A","year":"1993","journal-title":"Free Radical Biology and Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0891-5849","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(96)00291-9","article-title":"Apomorphine is a highly potent free radical scavenger in rat brain mitochondrial fraction","volume":"308","author":"Gassen M","year":"1996","journal-title":"European Journal of Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2999","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0027-5107(00)00073-7","article-title":"Dose finding in the Ames Salmonella assay","volume":"453","author":"Khromov-Borisov NN","year":"2000","journal-title":"Mutation Research","ISSN":"https:\/\/id.crossref.org\/issn\/0027-5107","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1383-5718(03)00132-3","article-title":"Differential mutagenic, antimutagenic and cytotoxic responses induced by apomorphine and its oxidation product, 8-oxo-apomorphine-semiquinone, in bacterial and yeast","volume":"539","author":"Picada JN","year":"2003","journal-title":"Mutation Research","ISSN":"https:\/\/id.crossref.org\/issn\/0027-5107","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0165-1218(84)90107-1","article-title":"Genotoxicity of apomorphine and various catecholamines in the Salmonella mutagenicity (Ames test) and in tests for primary DNA damage using repair-deficient B: subtilis strains (Rec assay)","volume":"137","author":"Suter W","year":"1984","journal-title":"Mutation Research","ISSN":"https:\/\/id.crossref.org\/issn\/0027-5107","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1248\/bpb1978.15.501","article-title":"Clastogenicity of apomorphine alkaloids in vitro","volume":"15","author":"Tadaki S","year":"1992","journal-title":"Journal of Pharmacobio-Dynamics","ISSN":"https:\/\/id.crossref.org\/issn\/0386-846X","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/ac50049a042","article-title":"Electrochemical studies of the oxidation pathways of apomorphine","volume":"51","author":"Cheng H-Y","year":"1979","journal-title":"Analytical Chemistry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-2700","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0076-6879(90)86127-H","article-title":"Characterization of o-quinone radicals in biological systems","volume":"186","author":"Kalyanaraman B","year":"2000","journal-title":"Methods in Enzymology","ISSN":"https:\/\/id.crossref.org\/issn\/0076-6879","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/abbi.1993.1189","article-title":"Monoamine metabolism provides an antioxidant defense in the brain against oxidant- and free radical-induced damage","volume":"302","author":"Liu J","year":"1993","journal-title":"Archives of Biochemistry and Biophysics","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9861","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(99)00088-9","article-title":"Mechanisms of apomorphine cytotoxicity towards rat glioma C6 cells: protection by bovine serum albumin and formation of apomorphine-protein conjugates","volume":"263","author":"El-Bacha RS","year":"1999","journal-title":"Neuroscience Letters","ISSN":"https:\/\/id.crossref.org\/issn\/0167-6253","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0014-2999(02)01553-4","article-title":"Differential neurobehavioral deficits induced by apomorphine and its oxidation product, 8-oxo-apomorphine-semiquinone, in rats","volume":"443","author":"Picada JN","year":"2002","journal-title":"European Journal of Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2999","issn-type":"print"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0920-9964(02)00426-7","article-title":"An oxidized form of apomorphine fails to induce stereotypy","volume":"63","author":"Picada JN","year":"2003","journal-title":"Schizophrenia Research","ISSN":"https:\/\/id.crossref.org\/issn\/0920-9964","issn-type":"print"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainres.2003.08.051","article-title":"Oxidative damage in brains of mice treated with apomorphine and its oxidized derivative","volume":"992","author":"Moreira JC","year":"2003","journal-title":"Brain Research","ISSN":"https:\/\/id.crossref.org\/issn\/0006-8993","issn-type":"print"},{"key":"ref35","series-title":"Free Radicals in Biology and Medicine","author":"Halliwell B","year":"1999","edition":"3"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0169-328X(03)00127-X","article-title":"DNA damage in brain cells of mice treated with an oxidized form of apomorphine","volume":"114","author":"Picada JN","year":"2003","journal-title":"Molecular Brain Research","ISSN":"https:\/\/id.crossref.org\/issn\/0169-328X","issn-type":"print"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0921-8777(94)00043-6","article-title":"The kinetics of repair of oxidative DNA damage (strand breaks and oxidized pyrimidines) in human cells","volume":"336","author":"Collins A","year":"1995","journal-title":"Mutation Research","ISSN":"https:\/\/id.crossref.org\/issn\/0027-5107","issn-type":"print"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J","article-title":"Single cell gel\/comet assay: guidelines for in vitro and in vivo genetic toxicology testing","volume":"35","author":"Tice RR","year":"2000","journal-title":"Environmental and Molecular Mutagenesis","ISSN":"https:\/\/id.crossref.org\/issn\/0893-6692","issn-type":"print"},{"key":"ref39","first-page":"85","article-title":"Repair of oxidative DNA damage - an important factor reducing cancer risk","volume":"48","author":"Brozmanov\u00e1 J","year":"2001","journal-title":"Neoplasma","ISSN":"https:\/\/id.crossref.org\/issn\/0028-2685","issn-type":"print"},{"key":"ref40","first-page":"671","article-title":"Importance of environmental context in the development of amphetamine- or apomorphine-induced stereotyped behavior after single and multiple doses","volume":"Biochemistry, and Behavior, 66","author":"Battisti JJ","year":"2000","journal-title":"Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0031-7012","issn-type":"print"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0028-3908(01)00178-2","article-title":"Continuous subcutaneous infusion of apomorphine rescues nigrostriatal dopaminergic terminals following MPTP injection in mice","volume":"42","author":"Battaglia G","year":"2002","journal-title":"Neuropharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3908","issn-type":"print"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-8993(01)02081-9","article-title":"Potent, hydroxyl radical-scavenging effect of apomorphine with iron and dopamine perfusion in rat striatum","volume":"896","author":"Chen Y-K","year":"2001","journal-title":"Brain Research","ISSN":"https:\/\/id.crossref.org\/issn\/0006-8993","issn-type":"print"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.58.suppl_1.S9","article-title":"Neuroprotection and dopamine agonists","volume":"58","author":"Schapira AHV","year":"2002","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.291.3.358","article-title":"Neuroprotection in Parkinson disease","volume":"291","author":"Schapira AHV","year":"2004","journal-title":"Journal of the American Medical Association","ISSN":"https:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"ref45","first-page":"125","article-title":"Monitoring neuroprotection and restorative therapies in Parkinson's disease","volume":"60","author":"Brooks DJ","year":"2000","journal-title":"Journal of Neural Transmission","ISSN":"https:\/\/id.crossref.org\/issn\/0300-9564","issn-type":"print"},{"key":"ref46","first-page":"214","article-title":"Double-blind, placebo-controlled study to assess safety and efficacy of riluzole as a neuroprotective drug in patients with early untreated Parkinson's disease","volume":"52","author":"Hunter C","year":"1999","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1212\/WNL.58.suppl_1.S33","article-title":"The role of dopamine agonists in the treatment of early Parkinson's disease","volume":"58","author":"Olanow WC","year":"2002","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"A32","DOI":"10.1038\/399a032","article-title":"Prospects for new restorative and neuroprotective treatments in Parkinson's disease","volume":"399","author":"Dunnett SB","year":"1999","journal-title":"Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"ref49","first-page":"171","article-title":"Neurotoxins induce apoptosis in dopamine neurons: protection by N-propargylamine-1\u00ae and (S)-aminoindan, rasagiline and TV1022","volume":"60","author":"Maruyama W","year":"2000","journal-title":"Journal of Neural Transmission","ISSN":"https:\/\/id.crossref.org\/issn\/0300-9564","issn-type":"print"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3810\/pgm.1999.08.648","article-title":"Medical and surgical treatment of Parkinson's disease: Strategies to slow symptom progression and improve quality of life","volume":"106","author":"Conley SC","year":"1999","journal-title":"Postgraduate Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0032-5481","issn-type":"print"},{"key":"ref51","first-page":"148","article-title":"The effects of chronic levodopa treatment on pre and post-synaptic markers of dopaminergic function in striatum of parkinsonian monkeys","volume":"12","author":"Rioux L","year":"1997","journal-title":"Movement Disorders","ISSN":"https:\/\/id.crossref.org\/issn\/0855-3185","issn-type":"print"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1060627","article-title":"Ubiquitination of a new form of alpha-synuclein by parkin from brain: implication for Parkinson's disease","volume":"293","author":"Shimura H","year":"2001","journal-title":"Science","ISSN":"https:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","article-title":"Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study","volume":"54","author":"Whone AL","year":"2003","journal-title":"Annals of Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"key":"ref54","first-page":"661","article-title":"Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine","volume":"13","author":"Gassen M","year":"1998","journal-title":"Movement Disorders","ISSN":"https:\/\/id.crossref.org\/issn\/0855-3185","issn-type":"print"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(98)00333-1","article-title":"Dopamine D2 receptor agonists protect against ischemia-induced hippocampal neurodegeneration in global cerebral ischemia","volume":"352","author":"O'Neill M","year":"1998","journal-title":"European Journal of Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0014-2999","issn-type":"print"},{"key":"ref56","first-page":"123","article-title":"Genes and oxidative stress in parkinsonism: cDNA microarray studies","volume":"91","author":"Mandel S","year":"2003","journal-title":"Advances in Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0091-3952","issn-type":"print"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1471-4159.2001.t01-1-00227.x","article-title":"Effects of R- and S-apomorphine on MPTP-induced nigrostriatal dopamine neuronal loss","volume":"77","author":"Gr\u00fcnblatt E","year":"2001","journal-title":"Journal of Neurochemistry","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3042","issn-type":"print"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2001.00397.x","article-title":"Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: Effect of R-apomorphine","volume":"78","author":"Gr\u00fcnblatt E","year":"2001","journal-title":"Journal of Neurochemistry","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3042","issn-type":"print"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1006\/bbrc.2000.2732","article-title":"Apomorphine up-regulates NGF and GDNF synthesis in cultural mouse astrocytes","volume":"272","author":"Ohta M","year":"2000","journal-title":"Biochemical and Biophysical Research Communications","ISSN":"https:\/\/id.crossref.org\/issn\/0006-291X","issn-type":"print"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0006-8993(01)02125-4","article-title":"Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage","volume":"898","author":"Fornai F","year":"2001","journal-title":"Brain Research","ISSN":"https:\/\/id.crossref.org\/issn\/0006-8993","issn-type":"print"}],"container-title":["Brazilian Journal of Medical and Biological Research"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/bjmbr\/v38n4\/5681.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T20:57:26Z","timestamp":1550264246000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0100-879X2005000400001&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0100-879X2005000400001"],"URL":"https:\/\/doi.org\/10.1590\/s0100-879x2005000400001","relation":{},"ISSN":["0100-879X"],"issn-type":[{"value":"0100-879X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}